These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Visual hallucinations and amnesia associated with the use of zolpidem. van Puijenbroek EP; Egberts AC; Krom HJ Int J Clin Pharmacol Ther; 1996 Jul; 34(7):318. PubMed ID: 8832310 [No Abstract] [Full Text] [Related]
7. A novel clinical pattern of visual hallucination after zolpidem use. Tsai MJ; Huang YB; Wu PC J Toxicol Clin Toxicol; 2003; 41(6):869-72. PubMed ID: 14677799 [TBL] [Abstract][Full Text] [Related]
8. Zolpidem misuse in two women with no psychiatric history: a crucial role of pleasant visual hallucinations. Kummer L; Rzewuska M; Sienkiewicz-Jarosz H; Mierzejewski P; Bienkowski P; Samochowiec J J Neuropsychiatry Clin Neurosci; 2012; 24(2):E32. PubMed ID: 22772691 [No Abstract] [Full Text] [Related]
10. Hallucinations with zolpidem and fluoxetine in an impaired driver. Coleman DE; Ota K J Forensic Sci; 2004 Mar; 49(2):392-3. PubMed ID: 15027567 [TBL] [Abstract][Full Text] [Related]
12. Pseudohallucinations after zolpidem intake: a case report. de Haas S; Dingemanse J; Hoever P; Cohen A; van Gerven J J Clin Psychopharmacol; 2007 Dec; 27(6):728-30. PubMed ID: 18004155 [No Abstract] [Full Text] [Related]
13. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction. Kito S; Koga Y Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779 [No Abstract] [Full Text] [Related]
14. [The differences in the contents of the leaflets of medicines containing zolpidem]. Pawłowska I; Pawłowski L; Kocić I Psychiatr Pol; 2014; 48(4):850-3. PubMed ID: 25314809 [No Abstract] [Full Text] [Related]
15. Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction. Elko CJ; Burgess JL; Robertson WO J Toxicol Clin Toxicol; 1998; 36(3):195-203. PubMed ID: 9656974 [TBL] [Abstract][Full Text] [Related]
17. Central nervous system side effects associated with zolpidem treatment. Toner LC; Tsambiras BM; Catalano G; Catalano MC; Cooper DS Clin Neuropharmacol; 2000; 23(1):54-8. PubMed ID: 10682233 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study. Schoedel KA; Sun H; Sellers EM; Faulknor J; Levy-Cooperman N; Li X; Kennedy WP; Cha JH; Lewis NM; Liu W; Bondiskey P; McCrea JB; Panebianco DL; Troyer MD; Wagner JA J Clin Psychopharmacol; 2016 Aug; 36(4):314-23. PubMed ID: 27253658 [TBL] [Abstract][Full Text] [Related]